¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"field ionization mass spectrometry"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
  • mass reflex
    Áý´Ü¹Ý»ç
  • mass screening
    Áý´Ü¼±º°°Ë»ç
  • mass spectrograph
    Áú·®ºÐ±¤»çÁø±â, Áú·®ºÐ¼®±â
  • mass spectrography
    Áú·®ºÐ±¤ºÐ¼®(¹ý)
  • mass spectrometer
    Áú·®ºÐ±¤°è
  • mass treatment
    Áý´ÜÄ¡·á
  • polypoid mass
    Æú¸³¸ð¾çµ¢ÀÌ, Æú¸³¸ð¾çÁ¾±«
  • sonolucent mass
    ÃÊÀ½ÆÄÅõ°úÁ¾±«
  • selective mass chemotherapy
    ¼±ÅÃÁý´ÜÈ­Çпä¹ý
  • auditory field
    û°¢¹üÀ§, û¿ª
  • altitudinal visual field defect
    ¼öÆò½Ã¾ß°á¼Õ
  • abutted field
    ÀÎÁ¢Á¶»ç¸é, Á¢ÃËÁ¶»ç¸é
  • B1 field gradient
    ȸÀüÀÚÀå±â¿ï±â
  • binocular field
    ¾ç¾È½Ã¾ß, µÎ´«½Ã¾ß
  • boost field
    Á¶»ç¿µ¿ª, Á¶»ç¸é
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
  • mass ligature
    Áý´Ü¹­±â
  • mass
    µ¢ÀÌ, µ¢¾î¸®, Áý´Ü, Áú·®
  • mass measurement
    Áú·®ÃøÁ¤
  • mass movement
    Áý´Ü¿îµ¿
  • mass polymerization
    µ¢ÀÌÁßÇÕ
  • mass radiography
    Áý´Ü¹æ»ç¼±ÃÔ¿µ¼ú, ¿¢½º¼±Áý´Ü°ËÁø
  • mass reflex
    Áý´Ü¹Ý»ç
  • mass screening
    Áý´Ü°Ë»ç
  • mass spectrograph
    Áú·®ºÐ±¤»çÁø±â
  • mass spectrography
    Áú·®ºÐ±¤°èÃø¹ý
  • mass spectrometer
    Áú·®ºÐ±¤°è
  • mass susceptibility
    Áú·®¹Î°¨µµ
  • mass treatment
    Áý´ÜÄ¡·á
  • mass measurement technique
    Áú·®ÃøÁ¤±â¼ú
  • mass miniature radiography
    Áý´Ü°£Á¢¹æ»ç¼±¼ú, ¿¢½º¼±Áý´Ü°£Á¢°ËÁø
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
  • lateral mass
    ¿ÜÃøµ¢ÀÌ, ¿ÜÃø±«(èâö°ÎÔ).
  • lateral mass
    °¡Âʵ¢ÀÌ
  • lateral mass of sacrum<³ª> pars lateralis ossis sacri
    (õ°ñÀÇ) ¿ÜÃø±« (èâö°ÎÔ).
  • law of conservation of mass
    Áú·®º¸Á¸(òõåÖÜÁðí)ÀÇ ¹ýÄ¢(ÛööÎ).
  • law of mass action
    Áú·®ÀÛ¿ë(òõåÖíÂéÄ) ¹ýÄ¢.
  • lean body mass =LBM
    ¸¶¸¥Ã¼Áß, Á¦Áö¹æÃ¼Áß(ð¶ò·Û¸ô÷ñì).
  • mass action
    Áú·®ÀÛ¿ë(òõåÖíÂéÄ), ´ë·®ÀÛ¿ë(ÓÞåÖíÂéÄ).
  • mass attenuation coefficient
    Áú·®°¨¼è°è¼ö
  • mass collision stopping power
    Áú·®Ãæµ¹ÀúÁö´É
  • mass consumption
    ¹ü¿ë.
  • mass contraction
    Áý´Ü¼öÃà(ó¢Ó¥â¥õê).
  • mass disaster
    ´ëÇü»ç°í, Âü»ç,
  • mass effect
    Áú·®È¿°ú
  • mass effect
    Á¾±«¿µÇâ, -È¿°ú
  • mass energy absorption coefficient
    Áú·®¿¡³ÊÁöÈí¼ö°è¼ö
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 11 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
  • mass number
    Áú·®¼ö(òõÕáâ¦)
  • mass spectrogram
    Áú·®ºÐ±¤µµ(òõÕáÝÂÎÃÓñ)
  • mass spectrograph
    Áú·®ºÐ±¤±â(òõÕáÝÂÎÃѦ)
  • mass spectrometer
    Áú·®ºÐ±¤°è(òõÕáÝÂÎÃͪ)
  • mass spectrum
    Áú·®(òõÕá) ½ºÆåÆ®·³
  • mass unit
    Áú·®´ÜÀ§(òõÕáÓ¤êÈ)
  • molar mass
    ¸ô Áú·®(òõÕá)
  • molecular mass
    ºÐÀÚÁú·®(ÝÂí­òõÕá)
  • nuclidic mass
    ´©Å¬¶óÀ̵å Áú·®(òõÕá)
  • quadrupole mass spectrometer
    »çÁß±ØÀÚ(ÞÌñìпí­) Áú·®ºÐ±¤°è(òõÕáÝÂÎÃͪ).
  • unit mass
    ´ÜÀ§(Ó¤êÈ) Áú·®(òõÕá)
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
  • lung field
    Æó¾ß
  • magnet field homogeneity
    ÀÚÀå±ÕÁú¼º
  • magnetic field
    ÀÚ(±â)Àå
  • magnetic field gradient
    ÀÚÀå°æ»ç
  • magnetic field gradient vector
    ÀÚÀå°æ»çº¤ÅÍ
  • magnetic field intensity
    ÀÚÀå°­µµ
  • magnetic field strength
    ÀÚÀå¼¼±â, ÀڱⰭµµ
  • magnetic fringe field
    ÀÚ±âÁÖº¯ÀÚÀå
  • magnetic induction field
    ÀÚ±âÀ¯µµÀÚÀå
  • main magnetic field inhomogenity
    ÁÖÀÚÀåºñ±ÕÁú¼º
  • middle lung field
    Á߯ó¾ß
  • near field
    ±Ù¿ª
  • radio-frequency field
    °íÁÖÆÄÀÚÀå
  • rectangular field of view (FOV)
    Á÷»ç°¢Çü½Ã¾ß
  • slice selection gradient field
    ÀýÆí¼±Åðæ»çÀå
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 4
FA false aneurysm; Families Anonymous; Fanconi anemia; far advanced; fatty acid; febrile antigen; femor...
EDS edema disease of swine; egg drop syndrome; Ehlers-Danlos syndrome; Emery-Dreifus syndrome; energy-di...
ES ejection sound; elastic stocking; electrical stimulus, electrical stimulation; electroshock; emergen...
HXIS hard x-ray imaging spectrometry
PCS palliative care service; Patient Care System; patterns of care study; pelvic congestion syndrome; ph...
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 4
FAB-MS Fast Atom Bombardment Mass Spectrometry
FT-ICR MS Fourier transform ion cyclotron resonance mass spectrometry
FT-MS Fourier transform mass spectrometry
GC/MS GC mass spectrometry
MS GC)-mass spectrometry
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • field echo
    ÀÚÀå ¿¡ÄÚ
  • field inhomogeneity
    ÀÚÀå ºÒ±ÕÀÏ, ÀÚÀå ºÒ±ÕÀϼº
  • field profile
    ÀÚÀå Ãø¸é »ó
  • field strength
    ÀÚÀå ¼¼±â, ÀÚÀå·Â
  • field survey
    ÇöÁö Á¶»ç
  • fringe field
    ÁÖº¯ ¾ß
  • fringe magnetic field strength
    ÁÖº¯ ÀÚÀå ¼¼±â
  • intermediate field MR scanner
    Áßµî ÀÚÀå Àڱ⠰ø¸í ½ºÄ³³Ê
  • irradiation field
    Á¶»ç ¾ß
  • magnet field homogeneity
    ÀÚÀå ±ÕÁú¼º
  • magnetic field gradient
    ÀÚÀå °æ»ç
  • magnetic field intensity
    ÀÚÀå °­µµ
  • magnetic fringe field
    ÀÚ±â ÁÖº¯ ÀÚÀå
  • main magnetic field inhomogenity
    ÁÖÀÚÀå ºñ±ÕÁú¼º
  • mastication field
    ÀúÀÛ ¿ª
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 4
relative molecular mass The sum of the atomic weight's of all the atoms constituting a molecule; the mass of a molecule relative to the mass of a standard atom, now 12C (taken as 12.000). Relative molecular mass (Mr) is the mass relative to the dalton and has no units.
See: atomic weight.
Synonym: molecular mass, molecular weight ratio, relative molecular mass.
(05 Mar 2000)
middle ear mass <radiology> Glomus tumour (multiple in 10%; 8% malignant), glomus tympanicum, from cochlear promontory, seldom erodes bone, glomus jugulare, invasion of middle ear from below, destruction of bony roof of jugular fossa and bony spur separating vein from carotid artery, abberant carotid artery (no bony margin), enlarged jugular bulb (dehiscent bony covering), cholesteatoma, rhabdomyosarcoma (orbit greater than nasopharynx greater than ear), adenocarcinoma (rare)
(12 Dec 1998)
middle mediastinal mass <radiology> Mnemonic: not VD, 90% malignant, Nodes, tumour (metastasis, lymphoma/leukaemia), infection, inhalational disease, Castleman disease, Tumour, primary lung, trachea, oesophagus carcinoma, Vascular, aneurysm, haematoma, Duplication cyst, bronchogenic, enteric, neurenteric
(12 Dec 1998)
molar mass See: molecular weight.
(05 Mar 2000)
molecular mass The sum of the atomic weight's of all the atoms constituting a molecule; the mass of a molecule relative to the mass of a standard atom, now 12C (taken as 12.000). Relative molecular mass (Mr) is the mass relative to the dalton and has no units.
See: atomic weight.
Synonym: molecular mass, molecular weight ratio, relative molecular mass.
(05 Mar 2000)
pill mass The mixture of drug(s), excipients, diluents and binders with a suitable amount of liquid to form a plastic mass which can be rolled into a long rod and cut into the appropriate number of units for pills to be rolled from.
Synonym: pill mass.
(05 Mar 2000)
pilular mass The mixture of drug(s), excipients, diluents and binders with a suitable amount of liquid to form a plastic mass which can be rolled into a long rod and cut into the appropriate number of units for pills to be rolled from.
Synonym: pill mass.
(05 Mar 2000)
complex liver mass in kids <radiology> Epithelial, FNH (uncommon, F greater than M), hepatic adenoma (uncommon, F greater than M), hepatoma (increased aFP in 90%), hepatoblastoma (increased aFP, less than 2 years of age), mesenchymal, hamartoma, cavernous haemangioma, haemangioendothelioma, embryonal rhabdomyosarcoma (obstructs common bile duct; less than 5 years of age), undifferentiated sarcoma, teratoma, abscess / haematoma / complicated cyst
(12 Dec 1998)
critical mass <chemistry, radiobiology> The minimum amount of mass of a combination of radioactive substances needed for the substances to generate and lose an exactly balanced number of neutrons to make a chain reaction which will keep going by itself.
(09 Oct 1997)
posterior mediastinal mass <radiology> Mnemonic: HALOVEEN, haematoma, abscess, lymph nodexs, osteophyte, vertebral (metastasis, plasmacytoma), extramedullary haematopoesis, oesophagus, neurogenic
(12 Dec 1998)
cystic pelvic mass <radiology> Physiologic ovarian cyst, The Big Three (ectopic, PID, endometriosis), ovarian neoplasm, nongynecologic mass
(12 Dec 1998)
cystic sellar mass <radiology> Arachnoid cyst, cystic craniopharyngioma, dermoid / epidermoid
(12 Dec 1998)
sclerotic cemental mass Benign fibro-osseous jaw lesions of unknown aetiology, occurring predominantly in middle-aged black females, which present as large painless radiopaque masses usually involving several quadrants of the jaw.
Synonym: florid osseous dysplasia, cemental dysplasia.
(05 Mar 2000)
solid renal mass <radiology> MALIGNANT until proven otherwise!, renal cell carcinoma (85%), other malignancy (10%), renal sarcoma, lymphoma, transitional cell carcinoma, metastases, benign mass (5%), oncocytoma, angiomyolipoma (fat present), fibroma
(12 Dec 1998)
solitary echogenic liver mass <radiology> Haemangioma, focal fatty infiltration, hepatoma, adenoma, focal nodular hyperplasia, hepatic lipoma
(12 Dec 1998)
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
  • rest mass
    Á¤Áö Áú·®
  • field
    ÀüÅõ,ÅõÁö,½Î¿ì´Ù,´ÙÅõ´Ù
  • Field Marshal
    À°±º ¿ø¼ö
  • Field prize
    Çʵå»ó
  • brick field
    º®µ¹°øÀå
  • center field
    ¼¾ÅÍ(ÀÇ ¼öºñÀ§Ä¡)
  • dark field
    (Çö¹Ì°æÀÇ) ¾Ï½Ã¾ß
  • dark field illumination
    ¾Ï½Ã¾ß Á¶¸í¹ý(Çö¹Ì°æ ½Ã·áÀÇ)
  • dark field microscope
    (±¤)ÇÑ¿Ü Çö¹Ì°æ;¾Ï½Ã¾ß Çö¹Ì°æ
  • electric field
    Àü°è
  • field
    µé;¹úÆÇ;¹ç;±¤Àå;Ç¥¸é;»êÁö;½Î¿òÅÍ;°æ±âÀå;³»(¿Ü)¾ß;ºÐ¾ß;¹ÙÅÁ;¿µ»ó¸é(coal field źÀü)
  • field allowance
    ÃâÁ¤ ¼ö´ç
  • field amvulance
    À̵¿¾ßÀüº´¿ø
  • field army
    ¾ßÀü±º
  • field artillery
    ¾ßÆ÷;¾ßÀüÆ÷º´
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 4
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 4
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 4
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 4
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 4
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 4
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 4
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 4
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 4
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 4
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 4
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 4
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 4
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 4
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 4
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 4
ÅëÇÕ°Ë»ö ¿Ï·á